Evolving concepts in neurogenic osteoporosis.
Convincing evidence has accumulated of regulation of bone by the central nervous system. The neural connection between brain and bone is mediated centrally by classic neurotransmitters and several neuropeptides, and peripherally by many of the same neurotransmitters and neuropeptides, albeit with actions opposite to their central effects. Pharmacologic blockade of ß2-adrenergic receptors or disruption of the gene encoding them increases bone mass, whereas increased activity of the sympathetic nervous system (SNS) contributes to bone loss. Brainstem serotonergic neurons regulate SNS activity and its modulation by leptin. Physiologic stimulation of osteoblastic nicotinic receptors results in proliferation and deposition of bone, whereas higher levels inhibit osteoblast function. Activation of sensory nerves has a centrally mediated action on bone, albeit poorly understood. The relative importance of, and interactions between autonomic, sensory, and peripheral nervous system actions on bone mass are also not clear in healthy individuals, and less so in pathologic states.
Qin
Weiping
W
Center of Excellence for the Medical Consequences of Spinal Cord Injury, Bronx, NY 10468, USA. Weiping.qin@mssm.edu
Bauman
William A
WA
Cardozo
Christopher P
CP
D000109:Acetylcholine / Q000502:physiology; D000818:Animals; D016723:Bone Remodeling / Q000502:physiology; D015740:Calcitonin Gene-Related Peptide / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D020738:Leptin / Q000502:physiology; D009479:Neuropeptides / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D010024:Osteoporosis / Q000503:physiopathology*; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D054969:Primary Dysautonomias / Q000503:physiopathology; D020521:Stroke / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000503:physiopathology
D020738:Leptin; D009479:Neuropeptides; D015740:Calcitonin Gene-Related Peptide; D000109:Acetylcholine; D009638:Norepinephrine
Biol Psychiatry. 2009 Sep 1;66(5):423-32
19446797
Am J Gastroenterol. 2003 Jan;98(1):128-34
12526948
Osteoporos Int. 2008 Apr;19(4):559-69
17924052
Circ Res. 2001 Nov 23;89(11):983-90
11717154
Endocrinology. 2009 Jan;150(1):144-52
18801900
J Neurol Sci. 2010 Feb 15;289(1-2):74-80
19740484
Trends Endocrinol Metab. 2010 Jul;21(7):411-8
20202858
Bone. 2009 Aug;45(2):309-20
19379851
Bone. 2004 May;34(5):869-80
15121019
Bone. 2006 Nov;39(5):1080-1086
16777503
J Bone Miner Metab. 2009;27(5):555-61
19436947
Clin Sci (Lond). 2007 Sep;113(5):233-41
17663660
Neurosci Lett. 2009 Oct 9;463(3):254-7
19647783
Arch Biochem Biophys. 2008 May 15;473(2):231-6
18410742
J Bone Miner Res. 2004 Dec;19(12):2049-56
15537449
Cell. 2009 Sep 4;138(5):976-89
19737523
J Rehabil Res Dev. 2008;45(2):283-96
18566946
Bone. 2001 Jun;28(6):603-8
11425648
Neuropeptides. 2007 Feb;41(1):25-31
17204323
J Bone Miner Res. 2008 Sep;23(9):1372-81
18410233
Cell Tissue Res. 2009 Nov;338(2):203-15
19820967
Stroke. 1998 Mar;29(3):607-12
9506600
Curr Med Res Opin. 2008 May;24(5):1379-84
18384711
Osteoporos Int. 2008 Jul;19(7):905-12
17924050
Cell Metab. 2010 Mar 3;11(3):231-8
20197056
Nature. 1998 Mar 26;392(6674):394-7
9537323
J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):111-20
18622080
Nature. 2005 Mar 24;434(7032):514-20
15724149
J Clin Psychopharmacol. 2008 Aug;28(4):411-7
18626268
Nat Med. 2007 Jul;13(7):791-801
17618270
Cell Tissue Res. 1991 Jun;264(3):469-80
1714353
Calcif Tissue Int. 2007 Apr;80(4):268-74
17401694
Cell. 2002 Nov 1;111(3):305-17
12419242
J Endocrinol. 1987 Dec;115(3):511-8
3502132
J Physiol. 2002 Oct 15;544(2):653-64
12381834
Cells Tissues Organs. 2010;191(6):489-99
20090303
Rheumatology (Oxford). 2000 Jul;39(7):692-5
10908684
J Intern Med. 2006 Oct;260(4):350-62
16961672
Spinal Cord. 2009 Jan;47(1):36-43
18957962
J Biol Chem. 2005 Aug 26;280(34):30192-200
15961387
J Appl Physiol (1985). 2006 May;100(5):1452-9
16410382
Bone. 2010 Jun;46(6):1591-6
20193788
J Neurobiol. 2004 Oct;61(1):30-44
15362151
J Neuroendocrinol. 2008 May;20 Suppl 1:69-74
18426503
Curr Pharm Biotechnol. 2005 Aug;6(4):319-24
16101470
Arch Intern Med. 2007 Jun 25;167(12):1246-51
17592097
FEBS Lett. 2010 Feb 19;584(4):817-24
20067796
Arch Phys Med Rehabil. 2007 Aug;88(8):1030-5
17678666
Neurology. 2009 Oct 27;73(17):1394-8
19858462